This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Vaxart, Inc.
Q42020
3/3/2021
Conference Operator
Call Operator
And welcome to the VaxArt fiscal year 2020 corporate update conference call and webinar. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. David Holmes of LifeSci Advisors. Please go ahead, sir.
David Holmes
Host, LifeSci Advisors
Thank you, Hector. Good afternoon and welcome to the Vaxar Corporate Update conference call. With me today are Andre Florio, Vaxar's Chief Executive Officer, and Sean Tucker, Accompanying Scientific Officer. During the course of the conference call, we will be making forward-looking statements regarding the future events, and the future performance of the company. These forward-looking statements may be accompanied by such words as should.
Andre Florio
Switch and save $652. It's okay. There's enough for everyone.
You're reading a preview of the VXRT Q4 2020 earnings call.
Free account.
Disclaimer